Lataa...
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Lowering of low-density lipoprotein cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) is clearly efficacious in the treatment and prevention of coronary artery disease. However, despite increasing use of statins, a significant number of coronary events still occur...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1592077/ https://ncbi.nlm.nih.gov/pubmed/17002798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-5-20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|